The following is a summary of “Dual seropositive nonerosive lupus arthritis: rhupus or not?” published in the February 2025 issue of Advances in Rheumatology by Pekdiker & Kara. Researchers conducted ...
ADI-001 is an allogeneic gamma delta CAR T-cell therapy that targets the B-cell antigen CD20. The Food and Drug Administration (FDA) has granted Fast Track designation to ADI-001 for the treatment ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback